Synthesis of Purines and Related Molecules by Cyclization ­Reactions of Heterocyclic Enamines

Abstract

A great variety of pharmacologically relevant fluorinated purine analogues are available by cyclization reactions of heterocyclic enamines with 1,3-dielectrophiles. The reactions usually proceed with excellent regioselectivities. As electrophiles, 1,3-diketones, enaminones or 3-chloro-2-en-1-ones were used. Other synthetic strategies are based on inverse-electron-demand Diels–Alder reactions of heterocyclic enamines with triazines. Purine analogues were further functionalized by transition-metal-catalyzed CH-coupling reactions or oxidative cyclizations, giving rise to more complex polycyclic products. Amidino-C-glycosides in their reactions with 1,3-dielectrophiles afforded pyrimidine-C-glycosides. Multicomponent reactions of heterocyclic enamines afforded complex products, including spirocyclic derivatives.

1 Introduction

2 1,3-Diketones

3 Enaminones

4 3-Chloro-2-en-1-ones

5 Triazines

6 Transition-Metal-Catalyzed Functionalizations

7 Pyrimidine-C-Nucleosides

8 Multicomponent Reactions

9 Conclusions

Key words

enamines - cyclization - 1,3-dielectrophiles - heterocycles - purines - regioselectivity

Publikationsverlauf

Eingereicht: 06. September 2021

Angenommen nach Revision: 15. September 2021

Artikel online veröffentlicht:
22. Oktober 2021

• References

• 1 Zielke CI, Suelter CH. Purine, Purine Nucleoside, and Purine Nucleotide Aminohydrolases, In The Enzymes, Vol. 4. Boyer PD. Academic Press; New York: 1971: 47
• 2a Niedzwicki JG, Kouttab NM, Mayer KH, Carpenter CC, Parks RE. Jr, Abushanab E, Abernethy DR. J. Acquired Immune Defic. Syndr. 1991; 4: 178
• 2b Salvatore D, Claudio MM, Anna PM. Clin. Chem. 1987; 33: 1675
• 2c Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, Hovanessian AG, Franco R. J. Immunol. 1997; 158: 3721
• 3a Ungerer JP. J, Oosthuizen HM, Retief JH, Bissbort SH. Chest 1994; 106: 33
• 3b Banales JL, Rivera-Martinez E, Perez-Gonzalez L, Selman M, Raymond Y, Nava A. Arch. Med. Res. 1999; 30: 358
• 4 Chiba S, Matsumoto H, Saitoh M, Kasahara M, Matsuya M, Kashiwagi MA. J. Neurol. Sci. 1995; 132: 170
• 5 Gakis C. Eur. Respir. J. 1996; 9: 632
• 6a Demeocq F, Viallard JL, Boumsell L, Richard Y, Chassagne J, Plagne R, Lemerle J, Bernard A. Leuk. Res. 1982; 6: 211
• 6b Carlucci F, Rosi F, Di Pietro C, Marinello E. Biochim. Biophys. Acta 1997; 1360: 203
• 7 Silverman RB. The Organic Chemistry of Drug Design, and Drug Action, 2nd ed. Elsevier Academic Press; Amsterdam: 2004: 617; ISBN 0-12-643732-7
• 8a Shewach DS, Krawczyk SH, Acevedo OL, Townsend LB. Biochem. Pharmacol. 1992; 44: 1697
• 8b Frieden C, Kurz LC, Gilbert HR. Biochemistry 1980; 19: 5303
• 9a See ref. 7.
• 9b Begue J.-P, Bonnet-Delpon D. Chimie Bioorganique et Medicinal du Fluor . EDP Sciences; Paris: 2005: 366; ISBN 2-86883-757-3
• 9c Kirsch P. Modern Fluoroorganic Chemistry . Wiley-VCH; Weinheim: 2004
• 9d Chambers RD. Fluorine in Organic Chemistry . Blackwell Publishing CRC Press; Boca Raton: 2004
• 9e Resnati G. Tetrahedron 1993; 49: 9385
• 9f Hiyama T. Organofluorine Compounds. Chemistry and Application 2000
• 9g Kleemann A, Engel J, Kutscher B, Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications 2001
• 9h Ismail FM. D. J. Fluorine Chem. 2002; 118: 27
• 9i Krisch P. Modern Fluoroorganic Chemistry . Wiley-VCH; Weinheim: 2004
• 10 Bojack G, Earnshaw CG, Klein R, Lindell SD, Lowinski K, Preus R. Org. Lett. 2001; 3: 839
• 11a Hedstrom L. Chem. Rev. 2009; 109: 2903
• 11b Markham GD, Bock CL, Schalk-Hihi C. Biochemistry 1999; 38: 4433
• 12 Review: Langer P. Synthesis 2002; 441

For reviews, see:
• 13a Langer P. Synlett 2006; 3369
• 13b Langer P. Eur. J. Org. Chem. 2007; 2233
• 13c Bellur E, Feist H, Langer P. Tetrahedron 2007; 63: 10865
• 13d Nawaz P, Sher M, Langer P. Synlett 2010; 2383
• 13e Hassan Z, Langer P. Synlett 2019; 30: 665
• 13f Langer P. Synlett 2021; DOI: DOI: 10.1055/s-0037-161078.
• 13g Dang TT, Kelzhanova NK, Abilov ZA, Turmukhanova MZ, Langer P. Synlett 2012; 23: 1283
• 13h Langer P, Freiberg W. Chem. Rev. 2004; 104: 4125
• 14 Review: Feist H, Langer P. Synthesis 2007; 327
• 15 Review: Langer P. Synlett 2007; 1016
• 16 Review: Langer P. Synlett 2009; 2205
• 17 A special aspect of this collaboration i.e., the cyclization of heterocyclic enamines with chromones, has been recently reviewed, see: Langer P.; Synlett; 2021, DOI: DOI: 10.1055/s-0040-1719830.
• 18a Dubey PK, Kumar RV, Naidu A, Kulkarni SM. A. Asian J. Chem. 2002; 14: 1129
• 18b Lee SCh, Choi JS, Oh JH, Park B, Kim YE, Lee JH, Shin D, Kim ChM, Hyun Y.-L, Lee ChS, Cho J.-M, Ro S. WO 2007083978, 2007 2007; 147, 817587
• 18c Kelly MG, Kincaid J, Duncton M, Sahasrabudhe K, Janagani S, Upasani RB, Wu G, Fang Y, Wei Zh-L. US 2006194801 Chem. Abstr. 2006; 145, 889269
• 18d Randolph JT, Chen H, Degoey DA, Flentge ChA, Flosi WJ, Grampovnik DJ, Huang PP, Hutchinson DK, Kempf DJ, Klein LL, Yeung MC. US 2005159469, Chem. Abstr. 2005; 143, 641882
• 18e Kivlighn SD, Zingaro GJ, Gabel RA, Broten TP, Schorn TW, Schaffer LW, Naylor EM, Chakravarty PK, Patchett AA, Greenlee WJ, Siegl PK. S. Am. J. Hypertens. 1995; 8: 58
• 19a Pagani ED, Dundore RL, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ. J. Cardiovasc. Pharmacol. 1994; 24: 403
• 19b Joseph EC, Rees JA, Dayan A. Toxicol. Pathol. 1996; 24: 436
• 19c Garvey DS, Saenz de Tejada I, Earl RA, Khanapure SP. US 6331543, 2001 2001; 136, 916407
• 20a Ida K, Otsubo N, Kuboyama T, Arai H, Watanabe A, Saki M, Hiura N, Manabe H, Takada H, Saito J. WO 2005082905, 2005 2005; 143, 979654
• 20b Magnuson S, Dixon J, Phillips B, Khire U, Wang L, Zhang Z, Patel M, Kumarasinghe ES, Wickens P, Olague A. WO 2007064932, 2007; Chem. Abstr. 2007; 147: 618350
• 20c Bavetsias V, Sun C, Bouloc N, Reynisson J, Workman P, Linardopoulos S, McDonald E. Bioorg. Med. Chem. Lett. 2007; 17: 6567
• 21 Zielke C. I., Suelter C. H.; Purine, Purine Nucleoside, and Purine Nucleotide Aminohydrolases, In The Enzymes, Vol. 4; Boyer P. D.; Academic Press: New York, 1971; 47
• 22a Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Med. Res. Rev. 2001; 21: 105
• 22b Maydanovych O, Beal PA. Chem. Rev. 2006; 106: 3397
• 22c Nair V.; IMPDH Inhibitors: Discovery of Antiviral Agents Against Emerging Diseases, In Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats; Torrence P. F.; John Wiley & Sons: Hoboken, 2005; Chap. 8,: 179–202.
• 22d Shu Q, Nair V. Med. Res. Rev. 2008; 219
• 23a Agarwal RP. Pharmacol. Ther. 1982; 17: 399
• 23b Weber G. Cancer Res. 1983; 43: 3466
• 24a Pankiewicz K. W., Goldstein B. M.; Inosine Mono Phosphate Dehydrogenase, In ACS Symposium Series 839; American Chemical Society: Washington DC, 2003;
• 25 Cappelli A, Nannicini C, Gallelli A, Giuliani G, Valenti S, la Pericot G, Mohr M, Anzini M, Mennuni L, Ferrari F, Caselli G, Giordani A, Peris W, Makovec F, Giorgi G, Vomero S. J. Med. Chem. 2008; 51: 2137
• 26 Supe L, Afzal S, Ejaz SA, Mahmood A, Hein M, Iaroshenko VO, Villinger A, Lecka A, Sévigny J, Iqbal J, Langer P. Eur. J. Org. Chem. 2018; 2629
• 27 Supe L, Hein M, Iaroshenko VO, Villinger A, Langer P. Tetrahedron 2020; 76: 131522
• 28 Iaroshenko VO, Ostrovskyi D, Petrosyan A, Mkrtchyan S, Villinger A, Langer P. J. Org. Chem. 2011; 76: 2899
• 29 Iaroshenko VO, Ali I, Mkrtchyan S, Semeniuchenko V, Ostrovskyi D, Langer P. Synlett 2012; 23: 2603
• 30 Ali I, Khan A, Hussain A, Ismail M, Hyder V, Ahmad VU, Iaroshenko VO, Langer P. Med. Chem. Res. 2016; 25: 2599
• 31 Goure WF, Leschinsky KL, Wratten SJ, Chupp JP. J. Agric. Food Chem. 1991; 39: 981
• 32 Ojima I, Lin S, Slater JC, Wang T, Pera P, Bernacki RJ, Ferlin C, Scambia G. Bioorg. Med. Chem. 2000; 8: 1619
• 33 Ferreira SB, Cost MS, Boechat N, Bezerra RJ. S, Genestra MS, Canto-Cavalheiro MM, Kover WB, Ferreira VF. Eur. J. Org. Chem. 2007; 1388
• 34 Iaroshenko VO, Specowius V, Vlach K, Vilches-Herrera M, Ostrovskyi D, Mkrtchyan S, Villinger A, Langer P. Tetrahedron 2011; 67: 5663
• 35 Königm B, Kümmel S, Cibulka R. Flavin Photocatalysis, In Chemical Photocatalysis 2013
• 36a See ref. 22d.
• 36b Erion MD, Reddy MR. J. Am. Chem. Soc. 1998; 120: 3295
• 36c See ref. 11a.
• 36d Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Med. Res. Rev. 2001; 21: 105
• 36e See ref. 22b.
• 36f Santaniello E, Ciuffreda P, Alessandrini L. Synthesis 2005; 509
• 37a Iaroshenko VO, Vilches-Herrera M, Gevorgyan A, Mkrtchyan S, Arakelyan K, Ostrovskyi D, Abbasi MS. A, Supe L, Hakobyan A, Villinger A, Volochnyuk DM, Tolmachev A, Langer P. Tetrahedron 2013; 69: 1217
• 37b Iaroshenko VO, Gevorgyan A, Mkrtchyan S, Grigoryan T, Movsisyan E, Villinger A, Langer P. ChemCatChem 2015; 7: 316
• 38 Iaroshenko VO, Mkrtchyan S, Gevorgyan A, Miliutina M, Villinger A, Volochnyuk D, Sosnovskikh VY, Langer P. Org. Biomol. Chem. 2012; 10: 890
• 39 Knepper I, Iaroshenko VO, Vilches-Herrera M, Domke L, Mkrtchyan S, Zahid M, Villinger A, Langer P. Tetrahedron 2011; 67: 5293
• 40 Iaroshenko V, Ali S, Babar TM, Dudkin S, Mkrtchyan M, Rama NH, Villinger A, Langer P. Tetrahedron Lett. 2011; 52: 373
• 41 Iaroshenko VO, Erben F, Mkrtchyan S, Hakobyan A, Vilches-Herrera M, Dudkin S, Bunescu A, Villinger A, Sosnovskikh VY, Langer P. Tetrahedron 2011; 67: 7946
• 42 Dudkin S, Iaroshenko VO, Tolmachev A, Villinger A, Sosnovskikh VY, Langer P. Org. Biomol. Chem. 2013; 11: 5351
• 43 Iaroshenko VO, Maalik A, Ostrovskyi D, Villinger A, Langer P. Tetrahedron 2011; 67: 8321 ; For related reactions, see references cited therein
• 44 Iaroshenko VO, Ostrovskyi D, Miliutina M, Maalik A, Villinger A, Tolmachev A, Volochnyuk DM, Langer P. Adv. Synth. Catal. 2012; 354: 2495
• 45 Mercier C, Ciccolini J. Trends Pharmacol. Sci. 2007; 28: 597
• 46 Périgaud C, Gosselin G, Imbach JL. Nucleosides Nucleotides 1992; 11: 903
• 47 Iaroshenko VO, Dudkin S, Sosnovskikh VY, Villinger A, Langer P. Eur. J. Org. Chem. 2013; 3166
• 48 Vilches-Herrera M, Knepper I, de Souza N, Villinger A, Sosnovskikh VY, Iaroshenko VO, Langer P. ACS Comb. Sci. 2012; 14: 434
• 49 Vilches-Herrera M, Spannenberg A, Langer P, Iaroshenko VO. Tetrahedron 2013; 69: 5955